Literature DB >> 31901072

Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity.

Sarah L Gaffen1, Niki M Moutsopoulos2.   

Abstract

The oral mucosa is a primary barrier site and a portal for entry of microbes, food, and airborne particles into the gastrointestinal tract. Nonetheless, mucosal immunity at this barrier remains understudied compared with other anatomical barrier sites. Here, we review basic aspects of oral mucosal histology, the oral microbiome, and common and clinically significant diseases that present at oral mucosal barriers. We particularly focus on the role of interleukin-17 (IL-17)/T helper 17 (TH17) responses in protective immunity and inflammation in the oral mucosa. IL-17/TH17 responses are highly relevant to maintaining barrier integrity and preventing pathogenic infections by the oral commensal fungus Candida albicans On the other hand, aberrant IL-17/TH17 responses are implicated in driving the pathogenesis of periodontitis and consequent bone and tooth loss. We discuss distinct IL-17-secreting T cell subsets, emphasizing their regulation and function in oropharyngeal candidiasis and periodontitis.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31901072      PMCID: PMC7068849          DOI: 10.1126/sciimmunol.aau4594

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  123 in total

1.  CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model.

Authors:  Pushpa Pandiyan; Heather R Conti; Lixin Zheng; Alanna C Peterson; Douglas R Mathern; Nydiaris Hernández-Santos; Mira Edgerton; Sarah L Gaffen; Michael J Lenardo
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

2.  Breaking a Vicious Cycle.

Authors:  Klaus Ley
Journal:  N Engl J Med       Date:  2017-03-23       Impact factor: 91.245

3.  Mutual interplay between IL-17-producing γδT cells and microbiota orchestrates oral mucosal homeostasis.

Authors:  Anneke Wilharm; Yaara Tabib; Maria Nassar; Annika Reinhardt; Gabriel Mizraji; Inga Sandrock; Oded Heyman; Joana Barros-Martins; Yuval Aizenbud; Abed Khalaileh; Luba Eli-Berchoer; Eran Elinav; Asaf Wilensky; Reinhold Förster; Herve Bercovier; Immo Prinz; Avi-Hai Hovav
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-28       Impact factor: 11.205

Review 4.  The oral microbiome in health and disease.

Authors:  William G Wade
Journal:  Pharmacol Res       Date:  2012-11-28       Impact factor: 7.658

5.  Transcriptional signature primes human oral mucosa for rapid wound healing.

Authors:  Ramiro Iglesias-Bartolome; Akihiko Uchiyama; Alfredo A Molinolo; Loreto Abusleme; Stephen R Brooks; Juan Luis Callejas-Valera; Dean Edwards; Colleen Doci; Marie-Liesse Asselin-Labat; Mark W Onaitis; Niki M Moutsopoulos; J S Gutkind; Maria I Morasso
Journal:  Sci Transl Med       Date:  2018-07-25       Impact factor: 17.956

Review 6.  Primary immunodeficiencies underlying fungal infections.

Authors:  Fanny Lanternier; Sophie Cypowyj; Capucine Picard; Jacinta Bustamante; Olivier Lortholary; Jean-Laurent Casanova; Anne Puel
Journal:  Curr Opin Pediatr       Date:  2013-12       Impact factor: 2.856

7.  A novel Th cell epitope of Candida albicans mediates protection from fungal infection.

Authors:  Eva Bär; André Gladiator; Sonia Bastidas; Bernd Roschitzki; Hans Acha-Orbea; Annette Oxenius; Salomé LeibundGut-Landmann
Journal:  J Immunol       Date:  2012-04-23       Impact factor: 5.422

8.  Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.

Authors:  Mathieu Goupil; Vincent Cousineau-Côté; Francine Aumont; Serge Sénéchal; Louis Gaboury; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  BMC Immunol       Date:  2014-10-26       Impact factor: 3.615

9.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.

Authors:  Heather R Conti; Fang Shen; Namrata Nayyar; Eileen Stocum; Jianing N Sun; Matthew J Lindemann; Allen W Ho; Justine Hoda Hai; Jeffrey J Yu; Ji Won Jung; Scott G Filler; Patricia Masso-Welch; Mira Edgerton; Sarah L Gaffen
Journal:  J Exp Med       Date:  2009-02-09       Impact factor: 14.307

10.  Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections.

Authors:  Heather R Conti; Alanna C Peterson; Lucas Brane; Anna R Huppler; Nydiaris Hernández-Santos; Natasha Whibley; Abhishek V Garg; Michelle R Simpson-Abelson; Gregory A Gibson; Anna J Mamo; Lisa C Osborne; Shrinivas Bishu; Nico Ghilardi; Ulrich Siebenlist; Simon C Watkins; David Artis; Mandy J McGeachy; Sarah L Gaffen
Journal:  J Exp Med       Date:  2014-09-08       Impact factor: 14.307

View more
  33 in total

1.  Call to Action: How to Tackle Emerging Nosocomial Fungal Infections.

Authors:  Michail S Lionakis; Tobias M Hohl
Journal:  Cell Host Microbe       Date:  2020-06-10       Impact factor: 21.023

2.  Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.

Authors:  Felix E Y Aggor; Timothy J Break; Giraldina Trevejo-Nuñez; Natasha Whibley; Bianca M Coleman; Rachel D Bailey; Daniel H Kaplan; Julian R Naglik; Wei Shan; Amol C Shetty; Carrie McCracken; Scott K Durum; Partha S Biswas; Vincent M Bruno; Jay K Kolls; Michail S Lionakis; Sarah L Gaffen
Journal:  Sci Immunol       Date:  2020-06-05

Review 3.  Infections in the monogenic autoimmune syndrome APECED.

Authors:  Vasileios Oikonomou; Timothy J Break; Sarah L Gaffen; Niki M Moutsopoulos; Michail S Lionakis
Journal:  Curr Opin Immunol       Date:  2021-08-18       Impact factor: 7.268

4.  Treponema denticola Induces Interleukin-36γ Expression in Human Oral Gingival Keratinocytes via the Parallel Activation of NF-κB and Mitogen-Activated Protein Kinase Pathways.

Authors:  Annie N Hinson; Colin G Hawkes; Christopher S Blake; Zackary R Fitzsimonds; Bin Zhu; Gregory Buck; Richard J Lamont; Daniel P Miller
Journal:  Infect Immun       Date:  2022-08-30       Impact factor: 3.609

5.  Periodontitis may induce gut microbiota dysbiosis via salivary microbiota.

Authors:  Jun Bao; Lili Li; Yangheng Zhang; Min Wang; Faming Chen; Shaohua Ge; Bin Chen; Fuhua Yan
Journal:  Int J Oral Sci       Date:  2022-06-23       Impact factor: 24.897

Review 6.  Innate type 1 immune response, but not IL-17 cells control tuberculosis infection.

Authors:  Noria Segueni; Muazzam Jacobs; Bernhard Ryffel
Journal:  Biomed J       Date:  2020-07-03       Impact factor: 4.910

7.  Calprotectin (S100A8/A9) Is an Innate Immune Effector in Experimental Periodontitis.

Authors:  Karen F Johnstone; Yuping Wei; Peter D Bittner-Eddy; Gerrit W Vreeman; Ian A Stone; Jonathan B Clayton; Cavan S Reilly; Travis B Walbon; Elisa N Wright; Susan L Hoops; William S Boyle; Massimo Costalonga; Mark C Herzberg
Journal:  Infect Immun       Date:  2021-06-07       Impact factor: 3.441

Review 8.  The microbial and host factors that govern Candida gastrointestinal colonization and dissemination.

Authors:  Animesh Anand Mishra; Andrew Y Koh
Journal:  Curr Opin Microbiol       Date:  2021-06-07       Impact factor: 7.584

9.  Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity.

Authors:  Drake Winslow Williams; Teresa Greenwell-Wild; Laurie Brenchley; Nicolas Dutzan; Andrew Overmiller; Andrew Phillip Sawaya; Simone Webb; Daniel Martin; George Hajishengallis; Kimon Divaris; Maria Morasso; Muzlifah Haniffa; Niki Maria Moutsopoulos
Journal:  Cell       Date:  2021-06-14       Impact factor: 66.850

10.  Tissue Damage in Radiation-Induced Oral Mucositis Is Mitigated by IL-17 Receptor Signaling.

Authors:  Jessica Saul-McBeth; John Dillon; Aaron Lee; Dylan Launder; Jacqueline M Kratch; Eanas Abutaha; Alexandria A Williamson; Allen G Schroering; Grace Michalski; Priosmita Biswas; Samuel R Conti; Amol C Shetty; Carrie McCracken; Vincent M Bruno; E Ishmael Parsai; Heather R Conti
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.